Claims
- 1. An isolated polypeptide comprised of an amino acid sequence selected from the group consisting of SEQ ID NO:2, SEQ ID NO:12, SEQ ID NO:4, SEQ ID NO:13 and SEQ ID NO:26.
- 2. An isolated polypeptide comprised of an amino acid sequence selected from the group consisting of SEQ ID NO:19, SEQ ID NO:20 and SEQ ID NO:25.
Parent Case Info
The present application is a continuation-in-part of co-pending U.S. patent application Ser. No. 09/199,586 filed on Nov. 25, 1998 now abandoned, which claims the benefit under 35 U.S.C. §119 (e) of U.S. Provisional Application No. 60/066,597, filed Nov. 26, 1997.
US Referenced Citations (1)
Number |
Name |
Date |
Kind |
5723299 |
Bell et al. |
Mar 1998 |
A |
Non-Patent Literature Citations (3)
Entry |
Wuyts et al. 1999, Eur J Biochem. vol. 260, pp. 421-429. Isolation of the CXC chemokines ENA-78, Gro-alpha adn Gro-gamma from tumor cells and leukocytes reveals NH2-terminal heterogeneity. Functional comparison of different naturall isoforms.* |
Incyte Pharmaceuticals Inc., INC819592, Mar. 5, 1996. |
Incyte Pharmaceuticals Inc., INC4304592, Jul. 9, 1998. |
Provisional Applications (1)
|
Number |
Date |
Country |
|
60/066597 |
Nov 1997 |
US |
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
09/199586 |
Nov 1998 |
US |
Child |
09/313458 |
|
US |